A Study to Evaluate the Long-Term Safety of BLI5100 in Patients With

See also
Status	Clinical Trial	Phase
Completed	`NCT01452776` - Long-Term Safety Study of TAK-438 in the Maintenance Treatment of Healed Erosive Esophagitis	Phase 3
Recruiting	`NCT05587309` - A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Erosive Esophagitis	Phase 3
Completed	`NCT04124926` - Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Erosive Esophagitis	Phase 3
Completed	`NCT01459367` - Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Maintenance Treatment of Healed Erosive Esophagitis	Phase 3
Completed	`NCT00228527` - Esomeprazole for Treatment of GERD in Pediatric Patients	Phase 4
Completed	`NCT01499368` - A Multi-center, Randomized, Double-blind Phase III Clinical Trial to Assess and Compare to the Efficacy and Safety of Lafutidine, Famotidine and Omeprazole-referenced in Korean Erosive Esophagitis Patients	Phase 3
Not yet recruiting	`NCT04613895` - Treatment Effect According to Timing of Administration of DWP14012 40 mg	N/A
Recruiting	`NCT02615184` - A Study of Dexlansoprazole in Healing and Maintenance of Healed Erosive Esophagitis (EE) in Children	Phase 2
Completed	`NCT02456935` - Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis	Phase 3
Completed	`NCT02028663` - Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis	Phase 2
Completed	`NCT03006874` - Study to Confirm the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis	Phase 3
Completed	`NCT02388724` - Efficacy and Safety of Oral Once-Daily Vonoprazan (TAK-438) in Participants With Erosive Esophagitis	Phase 3
Completed	`NCT01865825` - Proton Pump Inhibitor (PPI) Responsive Eosinophilic Esophagitis EoE: Gastroesophageal Reflux Disease (GERD) or Eosinophilic Esophagitis (EoE)?	N/A
Completed	`NCT02679508` - Vonoprazan Study in Patients With Erosive Esophagitis to Evaluate Long-term Safety	Phase 4
Completed	`NCT05050188` - A Study to Evaluate the Safety, Tolerability and Pharmacokinetics/Pharmacodynamics of Oral Doses of H008	Phase 1
Completed	`NCT01874535` - Rate of Complete Symptom Relief, Prevention of Symptom Relapse: Grades A and B Esophagitis of Esomeprazole Therapy	Phase 4
Completed	`NCT00206180` - NEXIUM® in the Treatment of Moderate and Severe Erosive Esophagitis	Phase 4
Completed	`NCT01630746` - A Randomized, Double-Blind, Multicenter Study to Evaluate the Acid-inhibitory and Dose-response Efficacy of TAK-438 (20 mg, 40 mg) in Patients With Proton Pump Inhibitor (PPI) - Resistant Erosive Esophagitis	Phase 3
Completed	`NCT01642615` - Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules for Healing of Erosive Esophagitis and Maintenance of Healed Erosive Esophagitis and Relief of Heartburn in Adolescents	Phase 2
Completed	`NCT01509261` - Efficacy Study of Ilaprazole to Treat Erosive Esophgitis	Phase 3

NCT number	NCT05890001
Study type	Interventional
Source	Braintree Laboratories
Contact
Status	Enrolling by invitation
Phase	Phase 3
Start date	April 5, 2023
Completion date	September 30, 2024

A Study to Evaluate the Long-Term Safety of BLI5100 in Patients With Gastroesophageal Reflux Disease

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms